PATENT CLAIM ANALYSIS

Application Number: 16069049
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "225800"]

Abstract:
The present invention relates to compounds of the following general formula (I) or (II): or a pharmaceutically acceptable salt and/or solvate thereof, for use in the treatment and/or in the prevention of ErbB2 dependent cancers, and pharmaceutical compositions containing such compounds.

Claim (Index 26):
The method according to  claim 13 , wherein R\u2032 3  is H.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.25641
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15768388', '13497924', '15023159', '14385808', '15768257']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7321544258224152
- 35 USC 102 Novelty (BERT): 0.5227268722298827
- Combined Prediction Score: 0.7112116704631619
- Mean Citation Score: 268.27641
- Max Citation Score: 282.37735
- Similarity Product: 187.575622420162

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test